Illinois Expands Medical Cannabis Patient and Dispensary Access

Qualifying Condition List Expanded

Illinois added chronic migraines, anxiety disorders, and opioid use disorder to the list of qualifying medical conditions under 410 ILCS 130/10. The three additions bring the state's total qualifying conditions to 44, matching the count in states like Ohio and Pennsylvania. Patients with documented diagnoses from licensed physicians can now apply for registry identification cards through the Department of Public Health portal.

The amended statute requires anxiety disorders to carry a DSM-5 diagnostic code and at least six months of documented treatment history. Opioid use disorder qualifies only when certified by an addiction medicine specialist or psychiatrist. Chronic migraines need documentation of 15 or more headache days per month over a three-month period.

Dispensary Siting Rules Relaxed

The state eliminated the 1,000-foot buffer requirement between medical dispensaries and schools, effective September 10, 2026. Under prior regulations codified in 68 Ill. Adm. Code 1290.210, medical dispensaries couldn't operate within 1,000 feet of a K-12 school building. The revised rule cuts that buffer to 500 feet, aligning Illinois with California and Michigan standards.

Existing dispensaries in non-compliant locations receive automatic grandfathering. New applicants must still comply with local zoning ordinances, which in Chicago and Springfield often impose stricter buffers than state minimums. The change doesn't affect adult-use dispensaries. Those remain subject to the 1,000-foot rule under separate statute.

Patient Purchase Limits Unchanged

Illinois maintained its 2.5-ounce 14-day purchase limit for medical cannabis patients despite advocacy for higher caps. The limit, set in 410 ILCS 130/10(a), hasn't changed since the program launched in 2014. Patients with written physician authorization can request a waiver to purchase up to 5 ounces per 14-day period, but fewer than 8% of registered patients hold such waivers according to 2025 Department of Public Health data.

The state's refusal to raise the base limit contrasts with recent moves in Pennsylvania (3.5 ounces per month) and Ohio (90-day supply with no fixed weight cap). Illinois patient advocates argue the 2.5-ounce limit forces high-consumption patients into the adult-use market, where prices average 22% higher due to the state's 10% adult-use excise tax.

Dispensary Count and Revenue Context

Illinois operates 110 medical dispensaries and 190 adult-use locations as of August 2026, generating $1.8 billion in combined annual sales. Medical sales account for $420 million of that total, down from $510 million in 2023. Patient migration to adult-use channels explains the decline. Product selection is broader there. Wait times are shorter.

Medical cannabis remains exempt from the state's 10% adult-use excise tax and the 6.25% state sales tax, but patients pay a 1% privilege tax under 410 ILCS 130/205. That tax generated $4.2 million in fiscal year 2025. Expanding the qualifying condition list could reverse the medical-market decline, but the Department of Financial and Professional Regulation hasn't published enrollment projections.

What Operators and Patients Watch Next

The next regulatory signal is a proposed rule on home cultivation for medical patients, expected by December 2026. Illinois currently prohibits home cultivation for medical patients, unlike 18 other medical-cannabis states. A draft rule circulated in July 2026 would allow patients to grow up to five plants, but the Department of Agriculture hasn't published a formal notice of proposed rulemaking.

For context on Illinois's evolving medical program, see the CannIntel topic hub on Illinois Medical Cannabis Program. Dispensary operators should monitor local zoning boards in Chicago, Aurora, and Naperville, where municipal councils are considering new buffer rules that could override the state's 500-foot standard.